Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses

Daniel B DiGiulio1, Maria Teresa Gervasi, Roberto Romero

  • 1Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Abstract

Insights

Microbial invasion of the amniotic cavity (MIAC) was detected in 6% of small-for-gestational-age (SGA) neonates using PCR, suggesting a role for intrauterine infection in fetal growth restriction. This finding was not apparent with traditional culture methods.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Microbiology

Background:

  • Microbial invasion of the amniotic cavity (MIAC) is linked to adverse pregnancy outcomes like preterm labor and PROM.
  • Intrauterine infection is a suspected contributor to fetal growth restriction (FGR).
  • The prevalence of MIAC in pregnancies complicated by small-for-gestational-age (SGA) fetuses remains largely uncharacterized.

Purpose of the Study:

  • To investigate the frequency, diversity, and relative abundance of microbes in amniotic fluid (AF) of women delivering SGA neonates.
  • To compare culture-based and molecular detection methods for MIAC in this population.

Main Methods:

  • Retrospective cohort study analyzing AF from 52 pregnancies with SGA neonates.
  • Utilized both cultivation techniques and molecular methods (broad-range and group-specific PCR assays targeting small subunit rDNA).
  • Correlated microbiologic findings with indicators of the maternal inflammatory response.

Main Results:

  • Cultivation methods yielded no microbial growth in any AF samples (0/52).
  • Molecular methods detected MIAC in 6% (3/52) of AF samples.
  • Intra-amniotic inflammation was observed in one of the three PCR-positive cases, compared to 6.1% of PCR-negative cases (P=0.2).

Conclusions:

  • PCR-based detection identified MIAC in a subset of pregnancies with SGA fetuses, even in the absence of labor at the time of AF collection.
  • These findings suggest that MIAC may play a role in the pathophysiology of FGR.
  • Molecular methods offer a more sensitive approach to detecting MIAC compared to traditional cultivation.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...